PXL-770 (now SCY-770) is a clinical stage, well-characterized oral therapy designed to address the underlying drivers of ADPKD by reducing cyst growth and disease progression A Phase 2 ...
A recent study in the Chinese Medical Journal reveals that circulating exosomal miR-122-3p is significantly upregulated in patients with metabolic dysfunction-associated steatotic liver disease. It ...
The growing interest in transdermal delivery as a metabolic support is reflected in Purisaki Berberine Patches. They are said to be a complementary method, although established lifestyle practices are ...
Metabolic dysfunction-associated steatotic liver disease (MASLD) has become a global public health challenge with rapidly ...
Kisspeptin‑10 (KP‑10) is a short, bioactive cleavage product of the KiSS1 precursor peptide that has gained prominence as a ...
TBI remains a major cause of death and long-term neurological disability worldwide, yet effective treatments for secondary injury are still lacking.
This work was supported by grants from the National Natural Science Foundation of China (Nos. 82471497, 82311530117, and ...
A single-atom nanozyme mimicking cytochrome c oxidase restores mitochondrial energy production in stem cells, shifting their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results